These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives. Baptista T; Kin NM; Beaulieu S; de Baptista EA Pharmacopsychiatry; 2002 Nov; 35(6):205-19. PubMed ID: 12518268 [TBL] [Abstract][Full Text] [Related]
7. Obesity in patients with severe mental illness: overview and management. McElroy SL J Clin Psychiatry; 2009; 70 Suppl 3():12-21. PubMed ID: 19570497 [TBL] [Abstract][Full Text] [Related]
11. [Clinical factors related to gains in body mass index (BMI) among patients under long-term antipsychotic treatment]. Koga M Seishin Shinkeigaku Zasshi; 2003; 105(4):473-88. PubMed ID: 12806910 [TBL] [Abstract][Full Text] [Related]
12. [Antipsychotic-induced weight gain: the possibilities of pharmacological correction]. Maslovskiĭ SIu; Kozlovskiĭ VL Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(8):81-6. PubMed ID: 19115510 [No Abstract] [Full Text] [Related]
13. When essential medications provoke new health problems: the metabolic effects of second-generation antipsychotics. Stein K J Am Diet Assoc; 2010 Jul; 110(7):992-1001. PubMed ID: 20630154 [No Abstract] [Full Text] [Related]
14. [Internist management of mental disorders]. Oberpichler-Schwenk H Med Monatsschr Pharm; 2010 Feb; 33(2):37. PubMed ID: 20184261 [No Abstract] [Full Text] [Related]
15. [Atypical antipsychotic induced weight gain and metabolic disorders]. Rojas G P; Poblete A C; Orellana G X; Rouliez A K; Liberman G C Rev Med Chil; 2009 Jan; 137(1):106-14. PubMed ID: 19399331 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular side-effects of antipsychotic drugs: the role of the autonomic nervous system. Leung JY; Barr AM; Procyshyn RM; Honer WG; Pang CC Pharmacol Ther; 2012 Aug; 135(2):113-22. PubMed ID: 22565090 [TBL] [Abstract][Full Text] [Related]
18. The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs. Falissard B; Mauri M; Shaw K; Wetterling T; Doble A; Giudicelli A; De Hert M Int Clin Psychopharmacol; 2011 Nov; 26(6):291-302. PubMed ID: 21876442 [TBL] [Abstract][Full Text] [Related]
19. Introduction: cardiovascular disease and metabolic risk factors in patients with mental illness. Newcomer JW CNS Spectr; 2008 Jun; 13(6 Suppl 10):1-14. PubMed ID: 18567978 [No Abstract] [Full Text] [Related]
20. Metabolic syndrome in an adolescent psychiatric unit. Dullur P; Eapen V; Trapolini T Australas Psychiatry; 2012 Oct; 20(5):444-5. PubMed ID: 23086316 [No Abstract] [Full Text] [Related] [Next] [New Search]